open access

Vol 15, No 1 (2009)
Research paper
Published online: 2009-02-24
Get Citation

Selected indicators of the antioxidant system in the blood of patients with lower limb varicose veins

Wirginia Krzyściak, Mariusz Kózka, Grzegorz Kazek, Marek Stępniewski
DOI: 10.5603/aa.9810
·
Acta Angiologica 2009;15(1):10-19.

open access

Vol 15, No 1 (2009)
Original papers
Published online: 2009-02-24

Abstract


Background. Reactive oxygen species (ROS) generation plays a crucial role in chronic venous disorders (CVD). The aim of this study was to investigate whether ROS generation is changed or decreased in patients affected by varicose disease.
Material and methods. The local vein production of ROS was assessed by measuring the Ferric Reducing Ability of Plasma (FRAP) levels and malondialdehyde (MDA) plasma concentrations in blood collected from the varicose veins and antecubital veins of 31 subjects (23 women and 8 men).
Results. An oxidant-antioxidant misbalance was detected, which displayed itself through a level of MDA concentration higher in plasma samples of varicose veins than in ulnar blood samples in both compared groups (women and men) (p ≤ 0.007; Wilcoxon test) as well as through a reduced Ferric Reducing Ability of Plasma of samples of varicose veins. FRAP concentration was higher in plasma samples of ulnar blood than in varicose veins (p ≤ 0.002; Wilcoxon test).
Conclusions. The study results point out the important role of oxidative stress developing in the capillary angiogenesis and varicose transformation of the surface veins in the legs.

Abstract


Background. Reactive oxygen species (ROS) generation plays a crucial role in chronic venous disorders (CVD). The aim of this study was to investigate whether ROS generation is changed or decreased in patients affected by varicose disease.
Material and methods. The local vein production of ROS was assessed by measuring the Ferric Reducing Ability of Plasma (FRAP) levels and malondialdehyde (MDA) plasma concentrations in blood collected from the varicose veins and antecubital veins of 31 subjects (23 women and 8 men).
Results. An oxidant-antioxidant misbalance was detected, which displayed itself through a level of MDA concentration higher in plasma samples of varicose veins than in ulnar blood samples in both compared groups (women and men) (p ≤ 0.007; Wilcoxon test) as well as through a reduced Ferric Reducing Ability of Plasma of samples of varicose veins. FRAP concentration was higher in plasma samples of ulnar blood than in varicose veins (p ≤ 0.002; Wilcoxon test).
Conclusions. The study results point out the important role of oxidative stress developing in the capillary angiogenesis and varicose transformation of the surface veins in the legs.
Get Citation

Keywords

varicose veins; antioxidant status; ferric reducing ability of plasma (FRAP) level; malondialdehyde (MDA) plasma concentrations

About this article
Title

Selected indicators of the antioxidant system in the blood of patients with lower limb varicose veins

Journal

Acta Angiologica

Issue

Vol 15, No 1 (2009)

Article type

Research paper

Pages

10-19

Published online

2009-02-24

Page views

933

Article views/downloads

3499

DOI

10.5603/aa.9810

Bibliographic record

Acta Angiologica 2009;15(1):10-19.

Keywords

varicose veins
antioxidant status
ferric reducing ability of plasma (FRAP) level
malondialdehyde (MDA) plasma concentrations

Authors

Wirginia Krzyściak
Mariusz Kózka
Grzegorz Kazek
Marek Stępniewski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl